HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke.

Abstract
Following the onset of an ischemic brain injury, the excitatory neurotransmitter glutamate is released. The excitotoxic effects of glutamate are a major contributor to the pathogenesis of a stroke. The aim of this study was to examine if overexpression of a glutamate transporter (GLT-1) reduces ischemic brain injury in a rat model of stroke. We generated an adeno-associated viral (AAV) vector expressing the rat GLT-1 cDNA (AAV-GLT1). Functional expression of AAV-GLT1 was confirmed by increased glutamate clearance rate in non-stroke rat brain as measured by in vivo amperometry. AAV-GLT1 was injected into future cortical region of infarction 3 weeks prior to 60 min middle cerebral artery occlusion (MCAo). Tissue damage was assessed at one and two days after MCAo using TUNEL and TTC staining, respectively. Behavioral testing was performed at 2, 8 and 14 days post-stroke. Animals receiving AAV-GLT1, compared to AAV-GFP, showed significant decreases in the duration and magnitude of extracellular glutamate, measured by microdialysis, during the 60 minute MCAo. A significant reduction in brain infarction and DNA fragmentation was observed in the region of AAV-GLT1 injection. Animals that received AAV-GLT1 showed significant improvement in behavioral recovery following stroke compared to the AAV-GFP group. We demonstrate that focal overexpression of the glutamate transporter, GLT-1, significantly reduces ischemia-induced glutamate overflow, decreases cell death and improves behavioral recovery. These data further support the role of glutamate in the pathogenesis of ischemic damage in brain and demonstrate that targeted gene delivery to decrease the ischemia-induced glutamate overflow reduces the cellular and behavioral deficits caused by stroke.
AuthorsBrandon K Harvey, Mikko Airavaara, Jason Hinzman, Emily M Wires, Matthew J Chiocco, Douglas B Howard, Hui Shen, Greg Gerhardt, Barry J Hoffer, Yun Wang
JournalPloS one (PLoS One) Vol. 6 Issue 8 Pg. e22135 ( 2011) ISSN: 1932-6203 [Electronic] United States
PMID21853027 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
Chemical References
  • Amino Acid Transport System X-AG
  • Glutamates
Topics
  • Amino Acid Transport System X-AG (metabolism)
  • Animals
  • Behavior, Animal (physiology)
  • Brain Infarction (complications, pathology, physiopathology)
  • Brain Injuries (complications, pathology, physiopathology, prevention & control)
  • Brain Ischemia (complications, pathology, physiopathology, prevention & control)
  • Cerebral Cortex (metabolism, pathology, physiopathology)
  • Dependovirus
  • Disease Models, Animal
  • Gene Expression Regulation
  • Glutamates (metabolism)
  • HEK293 Cells
  • Humans
  • In Situ Nick-End Labeling
  • Infarction, Middle Cerebral Artery (complications, pathology, physiopathology)
  • Male
  • Rats
  • Rats, Inbred F344
  • Recovery of Function (physiology)
  • Stroke (complications, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: